{
    "SPADE_N_15590": {
        "Sequence Information": {
            "Peptide Name": "Laxaphycin B",
            "Sequence": "XVXAXQXXTPLT",
            "Sequence Length": 12,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Anabaena laxa\n2. Anabaena torulosa",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Total structure and inhibition of tumor cell proliferation of laxaphycins",
                    "Pubmed ID": "17323939",
                    "Reference": "J Med Chem. 2007;50:1266-1279",
                    "Author": "Bonnard I, Rolland M, Salmon JM, Debiton E, Barthomeuf C, Banaigs B",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17323939"
                }
            ],
            "SPADE ID": "SPADE_N_15590",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11096",
                    "Similarity": 1.0,
                    "Sequence": "NPFKKIAHRHCYPKNECITTNGKKTCKDYSCCQIVLFGKKTRSACTVVAQ"
                },
                {
                    "SPADE_ID": "SPADE_N_15535",
                    "Similarity": 1.0,
                    "Sequence": "GALQVAQ"
                },
                {
                    "SPADE_ID": "SPADE_N_15586",
                    "Similarity": 1.0,
                    "Sequence": "VAQNTPLT"
                }
            ],
            "Hemolytic Activity": "Mouse fibroblasts L929:IC50=0.6 µM,Human fibroblasts:IC50=0.4 µM",
            "Target Organism": "Human ovarian carcinoma PA1(IC50=0.19±0.03µM),Human lung carcinoma A549(IC50=1µM),Human metastatic malignant melanoma M4Beu(IC50=0.4±0.03µM),Human breast adenocarcinoma MCF-7(IC50=1.0±0.12µM),Human colon adenocarcinoma DLD-1(IC50=6µM),Human prostate adenocarcinoma PC-3(IC50=0.8±0.01µM),Human lymphoblastic leukemia CCRF-CEM(IC50=1.11±0.15µM),Human lymphoblastic leukemia CCRF-CEM/VM-1(IC50=1.37±0.15µM),Human lymphoblastic leukemia CCRF-CEM/VLB100(IC50=1.02±0.05µM)"
        }
    }
}